Galectin-9
Galectin-9, encoded by the LGALS9 gene (also known as LGALS9A), is a beta-galactoside-binding S-type lectin of the galectin family. It acts as an eosinophil chemoattractant, inhibits angiogenesis and suppresses IFNG production by natural killer cells. Browse Assay Genie's current range of Galectin-9 research reagents below, or read on for the biology behind the target.
Galectin-9 belongs to the galectins, a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. It is classed as an S-type lectin and, in the HGNC classification, sits within the receptor ligands group alongside the other galectins. Annotated functions include acting as an eosinophil chemoattractant, inhibiting angiogenesis and suppressing IFNG production by natural killer cells, which places it at the interface of immune regulation and vascular biology.
The galectin-9 protein is found in the cytoplasm and nucleus and is also secreted, so it can act both inside cells and in the extracellular environment. The LGALS9 gene produces multiple alternatively spliced transcript variants, a point worth bearing in mind when choosing reagents for transcript or protein detection. Mouse and rat both carry an orthologous Lgals9 gene, which allows the biology to be examined in common rodent models.
The gene was previously named lectin, galactoside-binding, soluble, 9, and the symbol LGALS9A has also been used. NCBI Gene notes that galectin-9 is overexpressed in Hodgkin's disease tissue. It might participate in the interaction between Hodgkin and Reed-Sternberg (H&RS) cells and their surrounding cells, and so may play a role in the pathogenesis of the disease and its associated immunodeficiency. Researchers studying galectin-9 often compare it with related galectins to separate shared lectin properties from features specific to this family member.
Galectin-9 suppresses IFNG production by natural killer cells, making it a relevant protein for studying how lectins shape immune responses.
Galectin-9 acts as an eosinophil chemoattractant, so it is studied in work on eosinophil recruitment and migration.
Galectin-9 inhibits angiogenesis, which makes it of interest in studies of blood vessel formation and its control.
Galectin-9 is overexpressed in Hodgkin's disease tissue and may influence interactions between H&RS cells and their surroundings.
Galectin-9 is a beta-galactoside-binding lectin that modulates cell-cell and cell-matrix interactions. Annotated activities include acting as an eosinophil chemoattractant, inhibiting angiogenesis and suppressing IFNG production by natural killer cells. It is found in the cytoplasm and nucleus and is also secreted.
The HGNC symbol is LGALS9, for galectin 9. The symbol LGALS9A is a previous alias, and the older gene name was lectin, galactoside-binding, soluble, 9. The gene has multiple alternatively spliced transcript variants, so several transcripts are reported.
Mouse and rat both have an orthologous Lgals9 gene; check the datasheet of any product for its validated reactivity. Galectin-9 is overexpressed in Hodgkin's disease tissue and may contribute to its pathogenesis and associated immunodeficiency.
Other galectin family members and beta-galactoside-binding lectins related to Galectin-9.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O00182; product specifications from Assay Genie datasheets.